Amgen Inc.

Healthcare

NASDAQ:AMGN · NASDAQ Global Select

Market Cap $190.85B Beta 0.42 P/E (TTM) 24.5

$353.61 -0.13%

-$0.45 today

52W Low $267.83High $391.29

Vol 1.16M · Avg 2.67M

EPS (TTM)$14.44

Div Yield2.77%

Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+22.72%

Period High

$385.25

Period Low

$264.49

Latest

$354.19

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Merck & Co., Inc.

NYSE:MRK

$296.18B

Novartis AG

NYSE:NVS

$292.74B

Novo Nordisk A/S

NYSE:NVO

$196.77B

Gilead Sciences, Inc.

NASDAQ:GILD

$155.57B

Pfizer Inc.

NYSE:PFE

$149.27B

Danaher Corporation

NYSE:DHR

$127.55B

Bristol-Myers Squibb Company

NYSE:BMY

$116.63B

GSK plc

NYSE:GSK

$106.58B

Sanofi

NASDAQ:SNY

$106.44B

Boston Scientific Corporation

NYSE:BSX

$69.90B

What is the latest AMGN filing?

The latest filing shown is 11-K dated Jun 11, 2026.

How many recent filings does AMGN have?

Intrinsic Alpha currently shows 20 recent filings for AMGN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.